Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 814 across all filing types
Latest filing 2024-07-29 AGM Information
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
DiaSorin S.p.A. – Shareholders’ Meeting September 4, 2024 – Notice of call
AGM Information Classification · 99% confidence The document is explicitly titled 'Notice of call of Ordinary and Extraordinary Shareholders' Meeting' and details the date (September 4, 2024), agenda items (including statutory auditor engagement and amendments to articles of association), and procedures for shareholder participation (exclusively via Designated Representative due to COVID-19 related decrees). This content directly relates to the formal process and announcement for an Annual General Meeting (AGM). Although it is a 'Notice of call', which might suggest RPA, the comprehensive nature of the agenda, voting rights details, and procedural instructions for participation strongly align with the preparatory materials for an AGM, which is best categorized under AGM Information (AGM-R) rather than a generic Report Publication Announcement (RPA) or Regulatory Filing (RNS). The document is not the minutes or the results (which would be DVA), but the official call/notice for the meeting itself.
2024-07-29 English
DiaSorin S.p.A. - Assemblea degli Azionisti 4 settembre 2024 – Avviso di convocazione
AGM Information Classification · 100% confidence The document is an official notice titled "Avviso di convocazione di Assemblea Ordinaria e Straordinaria degli Azionisti" (Notice of Call for Ordinary and Extraordinary Shareholders' Meeting) for DiaSorin S.p.A., scheduled for September 4, 2024. It details the agenda, voting procedures (exclusively via designated representative due to COVID-19 related extensions), shareholder rights regarding questions and agenda integration, and references Italian financial regulations (TUF, Decreto Legge n. 18/2020). This content directly relates to the formal process and materials surrounding an Annual General Meeting (AGM). Although it is the notice of the meeting rather than the presentation materials themselves, the most specific category for AGM-related documentation is AGM-R (AGM Information). Since this is the official notice/call, it is closely related to the AGM process, but given the options, AGM-R is the best fit for core AGM documentation, or potentially PSI if it were soliciting votes more directly, but the focus here is the convocation and agenda. Given the explicit mention of the 'Assemblea degli Azionisti' (Shareholders' Meeting) and the agenda items, AGM-R is the most appropriate classification for the core meeting documentation.
2024-07-29 Italian
Diasorin H1 2024 Results Presentation
Investor Presentation Classification · 100% confidence The document is titled 'H1 2024 RESULTS' and contains financial highlights, key facts, and managerial outlook for the first half of 2024. It includes disclaimers, forward-looking statements, and non-IFRS performance measures. The structure and content (presentation slides format) are characteristic of an investor presentation used to communicate interim financial results to stakeholders. H1 2024
2024-07-29 English
DIASORIN RAISES FULL-YEAR 2024 GUIDANCE AS A RESULT OF THE POSITIVE PERFORMANCE OF THE FIRST SEMESTER OF THE YEAR
Earnings Release Classification · 100% confidence The document is a press release from DiaSorin S.p.A. announcing its financial results for the first semester (H1) of 2024. It includes detailed tables of financial performance (revenues, EBITDA, EBIT, net profit) and management commentary on these results. While it mentions the Board of Directors approved the consolidated financial statements, the document itself is the initial announcement of these results, not the full statutory report. Therefore, it is classified as an Earnings Release (ER). H1 2024
2024-07-29 English
DIASORIN AUMENTA LA GUIDANCE PER L’ESERCIZIO 2024 A SEGUITO DELL’ANDAMENTO POSITIVO DEI RISULTATI DEL 1° SEMESTRE
Earnings Release Classification · 100% confidence The document is a press release from DiaSorin S.p.A. dated July 29, 2024, announcing financial results for the first half of 2024 and an update to the 2024 guidance. It contains key financial highlights, tables of results, and management commentary on business performance. It is not a full interim report (which would be a longer, formal regulatory filing) but rather the initial announcement of these results, fitting the definition of an Earnings Release. H1 2024
2024-07-29 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "COMMUNICATION ON TOTAL AMOUNT OF VOTING RIGHTS pursuant to Article 85-bis, paragraph 4-bis, of Consob Regulation no. 11971/1999". It details changes in the number of voting rights held by shareholders due to the assignment or waiver of increased voting rights. This directly relates to the structure of shareholder voting power and rights, which falls under the category of voting rights announcements or related governance disclosures. Specifically, the content is a formal communication about the total amount of voting rights, which aligns closely with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports on the current state of voting rights after specific corporate actions related to those rights. Although it is not the final result of a vote (like after an AGM), it is a mandatory regulatory disclosure concerning voting rights mechanics.
2024-07-05 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.